Chromatographic, Mass and Cytotoxicity analysis of Isolates from Eichhornia crassipes’ Roots and Leaves against HepG2 and MCF7 cell lines

References

• Aboul-Enein, A. M., Shanab, S. M., Shalaby, E. A., Zahran, M. M., Lightfoot, D. A., & El-Shemy, H. A. (2014). Cytotoxic and antioxidant properties of active principals isolated from water hyacinth against four cancer cells lines. BMC Complementary and Alternative Medicine, 14(397), 11. https://doi.org/10.1186/1472-6882-14-397
   PubMedGoogle Scholar
• Azubuike, S. O., Muirhead, C., Hayes, L., & McNally, R. (2018). Rising global burden of breast cancer: The case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: A review. World Journal of Surgical Oncology, 16(1), 63. https://doi.org/10.1186/s12957-018-1345-2
   PubMedGoogle Scholar
• Baragaña, B., Norcross, N. R., Wilson, C., Porzelle, A., Hallyburton, I., Grimaldi, R., Osuna-Cabello, M., Norval, S., Riley, J., Stojanovski, L., Simeons, F. R. C., Wyatt, P. G., Delves, M. J., Meister, S., Duffy, S., Avery, V. M., Winzeler, E. A., Sinden, R. E., Wittlin, S., Gray, D. W., … Gilbert, I. H. (2016). Discovery of a quinoline-4-carboxamide derivative with a novel mechanism of action, multistage antimalarial activity, and potent in vivo efficacy. Journal of Medicinal Chemistry, 59(21), 9672–15. https://doi.org/10.1021/acs.jmedchem.6b00723
   PubMed Web of Science ®Google Scholar
• Bowe, C. L., Mokhtarzadeh, L., Venkatesan, P., Babu, S., Axelrod, H. R., Sofia, M. J., Kakarla, R., Chan, T. Y., Kim, J. S., Lee, H. J., Amidon, G. L., Choe, S. Y., Walker, S., & Kahne, D. (1997). Design of compounds that increase the absorption of polar molecules. Proceedings of the National Academy of Sciences of the United States of America, 94(22), 12218–12223. https://doi.org/10.1073/pnas.94.22.12218
   PubMed Web of Science ®Google Scholar
• Cancer_Genome_Atlas_Network. (2012). Comprehensive molecular portraits of human breast tumors. Nature.
   Google Scholar
• Di, L., Kerns, E. H., & Carter, G. T. (2009). Drug-like property concepts in pharmaceutical design. Current Pharmaceutical Design, 15(19), 2184–2194. https://doi.org/10.2174/138161209788682479
   PubMed Web of Science ®Google Scholar
• Flynn, E. (2007). Pharmacokinetic Parameters. In S. J. Enna & D. B. Bylund (Eds.), xPharm: The comprehensive pharmacology reference. Elsevier.
   Google Scholar
• Freshney, R. I. (2002). Cell line provenance. Cytotechnology, 39(2), 55–67. https://doi.org/10.1023/A:1022949730029
   PubMed Web of Science ®Google Scholar
• Ge, L., & Mordiffi, S. Z. (2017). Factors associated with higher caregiver burden among family caregivers of elderly cancer patients: A systematic review. Cancer Nursing, 40(6), 471–478. https://doi.org/10.1097/NCC.0000000000000445
   PubMed Web of Science ®Google Scholar
• Haggag, M. W., Abou-El-Ella, S. M., & Abouziena, H. F. (2017). Phytochemical analysis, antifungal, antimicrobial activities and application of eichhornia crassipes against some plant pathogens. Planta Daninha, 35(e017159560), 1-11. doi: 10.1590/s0100-83582017350100026
   Web of Science ®Google Scholar
• Hu, F.-Q., Liu, L.-N., Du, Y.-Z., & Yuan, H. (2009). Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. Biomaterials, 30(36), 6955–6963. https://doi.org/10.1016/j.biomaterials.2009.09.008
   PubMed Web of Science ®Google Scholar
• Hutchinson, L., & Kirk, R. (2011). High drug attrition rates—where are we going wrong? Nature Reviews. Clinical Oncology, 8(4), 189–190. https://doi.org/10.1038/nrclinonc.2011.34
   PubMed Web of Science ®Google Scholar
• Jo, H. Y., Kim, Y., Park, H. W., Moon, H. E., Bae, S., Kim, J., Kim, D. G., & Paek, S. H. (2015). The unreliability of MTT assay in the cytotoxic test of primary cultured glioblastoma cells. Experimental Neurobiology, 24(3), 235–245. https://doi.org/10.5607/en.2015.24.3.235
   PubMed Web of Science ®Google Scholar
• Johansen, S., Cvancarova, M., & Ruland, C. (2017). The effect of cancer patients’ and their family caregivers’ physical and emotional symptoms on caregiver burden. Cancer Nursing, 41(2), 91-99. https://doi.org/10.1097/NCC.0000000000000493
   Google Scholar
• Karakaş, D., Ari, F., & Ulukaya, E. (2017). The MTT viability assay yields strikingly false-positive viabilities although the cells are killed by some plant extracts. Turkish Journal of Biology = Turk Biyoloji Dergisi, 41(6), 919–925. https://doi.org/10.3906/biy-1703-104
   PubMed Web of Science ®Google Scholar
• Kern, E., & Di, L. (2008). Drug-like properties: Concepts, structure design and methods. Elsevier.
   Google Scholar
• Kumar, P., Nagarajan, A., & Uchil, P. D. (2018). Analysis of cell viability by the MTT assay. Cold Spring Harbor Protocols, 2018(6), pdb.prot095505. https://doi.org/10.1101/pdb.prot095505
   Google Scholar
• Kumar, S., Kumar, R., Dwivedi, A., & Pandey, A. K. (2014). In vitro antioxidant, antibacterial, and cytotoxic activity and in vivo effect of syngonium podophyllum and eichhornia crassipes leaf extracts on isoniazid induced oxidative stress and hepatic markers. BioMed Research International, 2014, 11, 1-11. https://doi.org/10.1155/2014/459452
   Web of Science ®Google Scholar
• Makhafola, T. J., & McGaw, L. J. (2017). Chapter 3 - Burden and health policy of cancers in Africa. In V. Kuete (Ed.), Medicinal spices and vegetables from Africa (pp. 93–107). Academic Press.
   Google Scholar
• McMaster, M. C. (2007). HPLC, A practical user’s guide. Wiley.
   Google Scholar
• Moreno, L., & Pearson, A. D. J. (2013). How can attrition rates be reduced in cancer drug discovery? Expert Opinion on Drug Discovery, 8(4), 363–368. https://doi.org/10.1517/17460441.2013.768984
   PubMed Web of Science ®Google Scholar
• Mtewa, A., Ngwira, K., Lampiao, F., Weisheit, A., & Tolo, C. J. J. D. R. D. (2018). Fundamental methods in drug permeability, Pka, LogP and LogDx determination. Journal of Drug Research and Development,4(2), 2470–1009.2146. DOI:10.16966/2470-1009.146
   Google Scholar
• Mtewa, A., Sesaazi, D. C., Lampiao, F.(2020). Structural and in silico characterization of small molecules isolated from Eichhornia crassipes. Evidence-Based Complementary and Alternative Medicine, 2020(Article ID 1375639), 1-11. https://doi.org/10.1155/2020/1375639
   Google Scholar
• Mtewa, A. G., Deyno, S., Ngwira, K., Lampiao, F., Peter, E. L., Ahovegbe, L. Y., … Sesaazi, D. C. (2018). Drug-like properties of anticancer molecules elucidated from Eichhornia crassipes. Journal of Pharmacognosy and Phytochemistry, 7(5), 2075–2079. https://www.phytojournal.com/archives/2018/vol7issue5/PartAJ/7-5-381-691.pdf
   Google Scholar
• Pan, S.-Y., Zhou, S.-F., Gao, S.-H., Yu, Z.-L., Zhang, S.-F., Tang, M.-K., … Ko, K.-M. (2013). New perspectives on how to discover drugs from herbal medicines: CAM’s outstanding contribution to modern therapeutics. Evidence-Based Complementary and Alternative Medicine, 2013, 1-11. https://doi.org/10.1155/2013/627375
   Web of Science ®Google Scholar
• Parkin, D. M. (2004). International variation. Oncogene, 23(38), 6329–6340. https://doi.org/10.1038/sj.onc.1207726
   PubMed Web of Science ®Google Scholar
• Patrick, G. (2017). An introduction to medicinal chemistry (6th ed.). Oxford University Press.
   Google Scholar
• Rostron, C. (2020). Drug design and development. Oxford University Press.
   Google Scholar
• Schneider, G. (2013). Prediction of drug-like properties. In Madame curie bioscience database [Online]. Landes Bioscience, 2000-2013. https://www.ncbi.nlm.nih.gov/books/NBK6404/. Accessed 12th January, 2020.
   Google Scholar
• Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., … Boyd, M. R. (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. JNCI: Journal of the National Cancer Institute, 82(13), 1107–1112. https://doi.org/10.1093/jnci/82.13.1107
   PubMed Web of Science ®Google Scholar
• Stewart, B. W., Bray, F., Forman, D., Ohgaki, H., Straif, K., Ullrich, A., & Wild, C. P. (2015). Cancer prevention as part of precision medicine: ‘plenty to be done’. Carcinogenesis, 37(1), 3-9. https://doi.org/10.1093/carcin/bgv166
   PubMed Web of Science ®Google Scholar
• Takebe, T., Imai, R., & Ono, S. (2018). The current status of drug discovery and development as originated in United States academia: the influence of industrial and academic collaboration on drug discovery and development. Clinical and Translational Science, 11(6), 597–606. https://doi.org/10.1111/cts.12577
   PubMed Web of Science ®Google Scholar
• Thorn, C. F., Oshiro, C., Marsh, S., Hernandez-Boussard, T., McLeod, H., Klein, T. E., & Altman, R. B. (2011). Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharmacogenetics and Genomics, 21(7), 440–446. https://doi.org/10.1097/FPC.0b013e32833ffb56
   PubMed Web of Science ®Google Scholar
• Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65(2), 87–108. https://doi.org/10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Tyagi, T., & Agarwal, M. (2017). Phytochemical screening and GC-MS analysis of bioactive constituents in the ethanolic extract of Pistia stratiotes L. and Eichhornia crassipes (Mart.) solms. Journal of Pharmacognosy and Phytochemistry., 6(1), 195–206. doi: 10.22159/ijcpr.2017.v9i3.19970
   Google Scholar
• Xie, Y., Ding, Z., Duan, W., & Ye, Q. (2011). Isolation and purification of terpenoids from Celastrus aculeatus Merr. by high-speed counter-current chromatography. Journal of Medicinal Plants Research., 6(12), 2520–2525. https://doi.org/10.5897/JMPR11.513
   Google Scholar